Research News – Monday, May 13, 2024

 

Synopsis: In this workshop, participants will learn how to process bulk RNA sequencing, single cell RNA sequencing, and spatial transcriptomics datasets using Bash, R, and Python programming languages. No informatics background, data, or experience is required. 

Applications due by the end of the day on July 1, 2024.

See attached flyer for additional information.

 

The Institutional Research Core Facility is hosting a Lunch and Learn Illumina seminar introducing the new XLEAP chemistry for our NextSeq2000 sequencer that will allow us to reduce costs. Please see attachment for additional information.

When:  Thursday, May 16^th

Where: BRC 109

When: 12:00 PM – 1:30 PM

Lunch will be provided for those who register.

 

NIH webinar titled “NIH Grants Process: A Brief Walk-Through for Beginners,” will be held May 15, 2024, from 12:00 to 1:30 p.m.

At this event, NIH staff will provide a general overview of the grants process and will walk through essential aspects of applying for funding. They will also offer information for finding the right fit for your research and discuss peer review, NIH and applicant institution roles and responsibilities, and resources to help along the way.

This webinar will include a substantial period for Q&A, featuring a panel of NIH experts answering questions submitted during registration, as well as additional queries raised during the live discussion.

Registration link: https://nih.zoomgov.com/webinar/register/WN_HVuQzY1-Ql-v1D-D9pFzBg#/registration

 

 

Office of Technology Commercialization presents the following opportunity for researchers to engage with industry (click here for more information, or email otc@ou.edu or gina-mcmillen@ouhsc.edu).  

An American pharmaceutical company focused on rare diseases seeks novel therapeutics with defined target, mechanism of action and proven efficacy for non-malignant hematological diseases.  Modalities of interest include small molecule, RNA-based, proteins/peptides and antibodies.  Therapeutics that act on SPHK1, HRI, BCL11A and ALAS2 are of particular interest.  Out of scope:  cell and gene therapies, repurposed or reformulated drugs, and treatments that act on LRF/SBTB7A, EED complex, LSD1, HIF-PHIs and TcRNs.   Submission entails a one-page 200-300 word non-confidential brief.  Deadline May 20th.

 

Continued Extension of Certain Flexibilities for Prospective Basic Experimental Studies with Human Participants (NOT-OD-24-118)

Reporting Data Management and Sharing (DMS) Plan Activities in the Research Performance Progress Report (RPPR) (NOT-OD-24-123)

Notice of Information: NIAID to Increase K99, K25, and K01 Salary and Research Support and R00 Years of Support (NOT-AI-24-038)

Notice of Change in the NIAID K24 Allowable Application Types and Eligibility Requirements (NOT-AI-24-043)

NIAID T32 Training Grants Maximum Number of Trainee Slots (NOT-AI-24-052)

Notice of Participation of the National Cancer Institute (NCI) in RFA-AG-25-004, "Safety and Early Efficacy Studies of Psychedelic-Assisted Therapy for Chronic Pain in Older Adults (UG3/UH3 Clinical Trial Required)" (NOT-CA-24-049)

The National Institutes of Health (NIH) Request for Information (RFI) on NIH-Wide Strategic Plan for Sexual and Gender Minority (SGM) Health Research
(NOT-OD-24-122)

Updates to NIH Training Grant Applications - Registration Open for June 5, 2024 Webinar (NOT-OD-24-124)

Request for Information (RFI) for the NIA Data Linkage Program (LINKAGE): Linking Research Data with Data from the Centers for Medicare and Medicaid Services (CMS) and other Federal Sources (NOT-AG-24-011)

Request for Information (RFI): Seeking Input on Existing Study Populations with Germline Results and Samples Available for Multi-Cancer Detection (MCD) Assay Testing (NOT-CA-24-051)

Request for Information: FDA-NIH Resource on Terminology for Clinical Research (NOT-OD-24-112)

Notice of Change to Increase K99 Salary Support, Research Support, and R00 Years of Support in PAR-23-071, NIAID Physician-Scientist Pathway to Independence Award (K99/R00 Independent Clinical Trial Not Allowed) (NOT-AI-24-039)

Notice of Change to Increase K99 Salary Support, Research Support, and R00 Years of Support in PAR-23-070, NIAID Physician-Scientist Pathway to Independence Award (K99/R00 Clinical Trial Required) (NOT-AI-24-040)

Notice of NIAID Withdrawal of Participation from PA-23-080 "Ruth L. Kirschstein National Research Service Award (NRSA) Short-Term Institutional Research Training Grant (Parent T35)" (NOT-AI-24-044)

Notice of Change to Research Objective and Scope and Award Information in RFA-AI-24-013, Cell and Gene Therapies for HIV Cure: Developing a Pipeline (P01 Clinical Trial Not Allowed) (NOT-AI-24-047)

Notice of Participation of the National Institute of Allergy and Infectious Diseases (NIAID) in PA-24-201, Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional) (NOT-AI-24-051)

Notice of Change to Update DMS-related Budget Instructions in PAR-23-145 "Maximizing Investigators Research Award (MIRA) for Early Stage Investigators (ESI) (R35 - Clinical Trial Optional)" (NOT-GM-24-031)

Notice of Change: Termination of RFA-MH-22-145, BRAIN Initiative: Standards to Define Experiments Related to the BRAIN Initiative (R01 Clinical Trial Not Allowed) (NOT-MH-24-295)

Notice of Change: Termination of RFA-MH-23-110 "BRAIN Initiative Fellows: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32)" (NOT-MH-24-315)

Notice of Change: Extension for PAR-21-315 Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional) (NOT-NS-24-074)

Notice of Change to receipt date for RFA-NS-23-023: BRAIN Initiative: Targeted BRAIN Circuits Planning Projects TargetedBCPP (R34 Clinical Trials Not Allowed) (NOT-NS-24-083)

Notice of Change to receipt date for RFA-NS-24-016 and RFA-NS-24-017 (NOT-NS-24-086)

Notice of Change: Cancelation of RFA-NS-23-025 "BRAIN Initiative: Exploratory Team-Research BRAIN Circuit Programs - eTeamBCP (U01 Clinical Trials Optional)" (NOT-NS-24-087)

Notice of Change: Cancelation of RFA-NS-23-024 "BRAIN Initiative: Targeted BRAIN Circuits Projects- TargetedBCP (R01 Clinical Trial Not Allowed)" (NOT-NS-24-088)

Notice of Change: Cancelation of RFA-NS-22-039 and RFA-NS-22-040 (NOT-NS-24-089)

Notice of Change: Cancelation of RFA-NS-22-041 "BRAIN Initiative: Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (U01 Basic Experimental Studies with Humans Required)"
(NOT-NS-24-090)

Notice of Change to Research Opportunity Title: Advancing Health Research through Ethical, Multimodal AI (NOT-OD-24-114)

Notice of Intent to Publish a Funding Opportunity Announcement for NEI Research for Low Vision and Blindness Accessibility Tools (R61/R33 Clinical Trial Optional) (NOT-EY-24-008)

Notice of Intent to Publish a Funding Opportunity Announcement for Examining the Impact of Artificial Intelligence (AI) on Healthcare Safety (R18) (NOT-HS-24-014)

Notice of Intent to Publish a Funding Opportunity Announcement for Limited Competition: NIMHD Initiative for Improving American Indian and Alaska Native Cancer Outcomes (U01- Clinical Trial Optional) (NOT-MD-24-015)

Notice of Special Interest (NOSI): Administrative Supplements for Supporting the Optimization, Calibration, and Dissemination of Imaging Phantoms (NOT-EB-24-009)

 

 

NOTE: When only one application is allowed per Institution according to the sponsor instructions, a one-page letter of intent summarizing the proposed project should be submitted to the Vice President for Research at least two months prior to the application deadline (unless otherwise noted).  The letters of intent will be reviewed and a single application will be chosen for submission from the University.

 

 

Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed) (PAR-24-152)
Application Deadline: June 25, 2024 and October 25, 2024

Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required) (PAR-24-214)
Application Deadline:  June 25, 2024 and October 25, 2024

Specialized Alcohol Research Centers (P50 Clinical trial Optional) (RFA-AA-24-007)
Application Deadline:  November 15, 2024

 

Comprehensive Alcohol Research Centers (P60 Clinical trial Optional) (RFA-AA-24-008)
Application Deadline:  November 15, 2024

 

Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRC) (P50 Clinical Trial Optional) (RFA-AR-25-002)
Application Deadline:  July 03, 2024

 

ML/AI Tools to Advance Genomic Translational Research (MAGen) - Development Sites (UG3/UH3 Clinical Trials Not Allowed) (RFA-HG-24-004)
Application Deadline:  July 26, 2024

 

ML/AI Tools to Advance Genomic Translational Research (MAGen) - Coordinating Center (UG3/UH3, Clinical Trials Not Allowed) (RFA-HG-24-005)
Application Deadline:  July 26, 2024

 

Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01 Independent Clinical Trial Required) (RFA-HL-25-008)
Application Deadline:  October 17, 2024 and February 17, 2025

 

Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01 Independent Clinical Trial Not Allowed) (RFA-HL-25-009)

Application Deadline:  October 14, 2024 and February 17, 2025

Exploratory/Developmental Research for World Trade Center Health Program Evidence-based Strategies to Improve Treatment Effectiveness, Diagnostic Practices, and Program Evaluation (R21) (RFA-OH-25-001)

Application Deadline:  October 29, 2024